First in Human Long-Acting Gene Silencing Therapy Significantly Lowers Heart Disease Risk Marker with One Injection September 9, 2026 by Leo Leave a Comment Results suggest one shot could keep Lipoprotein(a) levels lower for nearly a year Source: First in Human Long-Acting Gene Silencing Therapy Significantly Lowers Heart Disease Risk Marker with One Injection Fascinating.
Leave a Reply